Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neutropenia Biologic Drug Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Kyowa Kirin
Amgen
Cellerant Therapeutics
Pfizer
CVS Health
Baxter International
Partner Therapeutics
Sanofi
Novartis
Teva Pharmaceutical Industries Ltd
Dong-A ST CO Ltd
By Type:
Filgrastim
Lenograstim
Sargramostim
Pegfilgrastim
Lipegfilgrastim
By Application:
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neutropenia Biologic Drug Treatment Market Overview 2018-2029
-
1.1 China Neutropenia Biologic Drug Treatment Industry Development Overview
-
1.2 China Neutropenia Biologic Drug Treatment Industry Development History
-
1.3 China Neutropenia Biologic Drug Treatment Industry Market Size (2018-2029)
-
1.4 China Neutropenia Biologic Drug Treatment Market Analysis by Type from Production Side
-
1.4.1 China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Filgrastim (2018-2029)
-
1.4.2 China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Lenograstim (2018-2029)
-
1.4.3 China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Sargramostim (2018-2029)
-
1.4.4 China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Pegfilgrastim (2018-2029)
-
1.4.5 China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Lipegfilgrastim (2018-2029)
-
1.5 China Neutropenia Biologic Drug Treatment Market Analysis by Application from Consumption End
-
1.5.1 China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
1.5.2 China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.5.3 China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.6 China Neutropenia Biologic Drug Treatment Market Analysis by Region
-
1.6.1 North China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
Chapter 2 China Neutropenia Biologic Drug Treatment Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neutropenia Biologic Drug Treatment Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neutropenia Biologic Drug Treatment Market Status and Competition Analysis in 2023
-
2.2.3 China Neutropenia Biologic Drug Treatment Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neutropenia Biologic Drug Treatment Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neutropenia Biologic Drug Treatment Industry Development
Chapter 3 Neutropenia Biologic Drug TreatmentIndustry Chain Analysis
-
3.1 Neutropenia Biologic Drug Treatment Industry Chain
-
3.2 Neutropenia Biologic Drug Treatment Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neutropenia Biologic Drug Treatment Market
-
3.3 Neutropenia Biologic Drug Treatment Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neutropenia Biologic Drug Treatment Market
Chapter 4 China Neutropenia Biologic Drug Treatment Market, by Type
-
4.1 China Neutropenia Biologic Drug Treatment Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neutropenia Biologic Drug Treatment Total Production Volume and Growth Rate from Production Side
-
4.5 China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate, by Type
-
4.5.1 China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Filgrastim
-
4.5.2 China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Lenograstim
-
4.5.3 China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Sargramostim
-
4.5.4 China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Pegfilgrastim
-
4.5.5 China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Lipegfilgrastim
Chapter 5 China Neutropenia Biologic Drug Treatment Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neutropenia Biologic Drug Treatment Total Market Size and Growth Rate from Consumption End
-
5.5 China Neutropenia Biologic Drug Treatment Market Size and Growth Rate, by Application
-
5.5.1 China Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Online Pharmacies
-
5.5.2 China Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Retail Pharmacies
-
5.5.3 China Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Hospital Pharmacies
Chapter 6 China Neutropenia Biologic Drug Treatment Market, by Region
-
6.1 China Neutropenia Biologic Drug Treatment Production Volume and Production Value, by Region
-
6.2 China Neutropenia Biologic Drug Treatment Sales Volume and Sales Value, by Region
Chapter 7 North China Neutropenia Biologic Drug Treatment Market Analysis
-
7.1 North China Neutropenia Biologic Drug Treatment Market, by Type
-
7.2 North China Neutropenia Biologic Drug Treatment Market, by Application
Chapter 8 Central China Neutropenia Biologic Drug Treatment Market Analysis
-
8.1 Central China Neutropenia Biologic Drug Treatment Market, by Type
-
8.2 Central China Neutropenia Biologic Drug Treatment Market, by Application
Chapter 9 South China Neutropenia Biologic Drug Treatment Market Analysis
-
9.1 South China Neutropenia Biologic Drug Treatment Market, by Type
-
9.2 South China Neutropenia Biologic Drug Treatment Market, by Application
Chapter 10 East China Neutropenia Biologic Drug Treatment Market Analysis
-
10.1 East China Neutropenia Biologic Drug Treatment Market, by Type
-
10.2 East China Neutropenia Biologic Drug Treatment Market, by Application
Chapter 11 Northeast China Neutropenia Biologic Drug Treatment Market Analysis
-
11.1 Northeast China Neutropenia Biologic Drug Treatment Market, by Type
-
11.2 Northeast China Neutropenia Biologic Drug Treatment Market, by Application
Chapter 12 Southwest China Neutropenia Biologic Drug Treatment Market Analysis
-
12.1 Southwest China Neutropenia Biologic Drug Treatment Market, by Type
-
12.2 Southwest China Neutropenia Biologic Drug Treatment Market, by Application
Chapter 13 Northwest China Neutropenia Biologic Drug Treatment Market Analysis
-
13.1 Northwest China Neutropenia Biologic Drug Treatment Market, by Type
-
13.2 Northwest China Neutropenia Biologic Drug Treatment Market, by Application
Chapter 14 Company Profiles
-
14.1 Kyowa Kirin
-
14.1.1 Kyowa Kirin Company Profile
-
14.1.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Amgen
-
14.2.1 Amgen Company Profile
-
14.2.2 Amgen Neutropenia Biologic Drug Treatment Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Cellerant Therapeutics
-
14.3.1 Cellerant Therapeutics Company Profile
-
14.3.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Pfizer
-
14.4.1 Pfizer Company Profile
-
14.4.2 Pfizer Neutropenia Biologic Drug Treatment Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 CVS Health
-
14.5.1 CVS Health Company Profile
-
14.5.2 CVS Health Neutropenia Biologic Drug Treatment Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Baxter International
-
14.6.1 Baxter International Company Profile
-
14.6.2 Baxter International Neutropenia Biologic Drug Treatment Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Partner Therapeutics
-
14.7.1 Partner Therapeutics Company Profile
-
14.7.2 Partner Therapeutics Neutropenia Biologic Drug Treatment Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Sanofi
-
14.8.1 Sanofi Company Profile
-
14.8.2 Sanofi Neutropenia Biologic Drug Treatment Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Novartis
-
14.9.1 Novartis Company Profile
-
14.9.2 Novartis Neutropenia Biologic Drug Treatment Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Teva Pharmaceutical Industries Ltd
-
14.10.1 Teva Pharmaceutical Industries Ltd Company Profile
-
14.10.2 Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Dong-A ST CO Ltd
-
14.11.1 Dong-A ST CO Ltd Company Profile
-
14.11.2 Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neutropenia Biologic Drug Treatment Industry Research Conclusions
-
15.2 Neutropenia Biologic Drug Treatment Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neutropenia Biologic Drug Treatment Industry Market Size (2018-2029)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Filgrastim (2018-2029)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Lenograstim (2018-2029)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Sargramostim (2018-2029)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Pegfilgrastim (2018-2029)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume, Production Value and Growth Rate of Lipegfilgrastim (2018-2029)
-
Figure China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
Figure China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure North China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
Figure Central China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
Figure South China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
Figure East China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neutropenia Biologic Drug Treatment Market Size and Growth Rate from 2018-2029
-
Figure Neutropenia Biologic Drug Treatment Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neutropenia Biologic Drug Treatment Market Share by Type in 2018
-
Figure China Neutropenia Biologic Drug Treatment Market Share by Type in 2023
-
Figure China Neutropenia Biologic Drug Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Filgrastim (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Lenograstim (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Sargramostim (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Pegfilgrastim (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume and Growth Rate of Lipegfilgrastim (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Market Share by Application in 2018
-
Figure China Neutropenia Biologic Drug Treatment Market Share by Application in 2023
-
Figure China Neutropenia Biologic Drug Treatment Total Market Size and Growth Rate from Consumption End
-
Figure China Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Online Pharmacies (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Table China Neutropenia Biologic Drug Treatment Production Volume by Region (2018-2023)
-
Table China Neutropenia Biologic Drug Treatment Production Volume Share by Region (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Production Volume Share by Region (2018-2023)
-
Table China Neutropenia Biologic Drug Treatment Production Value by Region (2018-2023)
-
Table China Neutropenia Biologic Drug Treatment Production Value Share by Region (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Production Value Share by Region (2018-2023)
-
Table China Neutropenia Biologic Drug Treatment Sales Volume by Region (2018-2023)
-
Table China Neutropenia Biologic Drug Treatment Sales Volume Share by Region (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Sales Volume Share by Region (2018-2023)
-
Table China Neutropenia Biologic Drug Treatment Sales Value by Region (2018-2023)
-
Table China Neutropenia Biologic Drug Treatment Sales Value Share by Region (2018-2023)
-
Figure China Neutropenia Biologic Drug Treatment Sales Value Share by Region (2018-2023)
-
Table North China Neutropenia Biologic Drug Treatment Production Volume by Type (2018-2023)
-
Table North China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Figure North China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Table North China Neutropenia Biologic Drug Treatment Sales Volume by Application (2018-2023)
-
Table North China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Figure North China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Table Central China Neutropenia Biologic Drug Treatment Production Volume by Type (2018-2023)
-
Table Central China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Figure Central China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Table Central China Neutropenia Biologic Drug Treatment Sales Volume by Application (2018-2023)
-
Table Central China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Figure Central China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Table South China Neutropenia Biologic Drug Treatment Production Volume by Type (2018-2023)
-
Table South China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Figure South China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Table South China Neutropenia Biologic Drug Treatment Sales Volume by Application (2018-2023)
-
Table South China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Figure South China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Table East China Neutropenia Biologic Drug Treatment Production Volume by Type (2018-2023)
-
Table East China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Figure East China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Table East China Neutropenia Biologic Drug Treatment Sales Volume by Application (2018-2023)
-
Table East China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Figure East China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neutropenia Biologic Drug Treatment Production Volume by Type (2018-2023)
-
Table Northeast China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Table Northeast China Neutropenia Biologic Drug Treatment Sales Volume by Application (2018-2023)
-
Table Northeast China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neutropenia Biologic Drug Treatment Production Volume by Type (2018-2023)
-
Table Southwest China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Table Southwest China Neutropenia Biologic Drug Treatment Sales Volume by Application (2018-2023)
-
Table Southwest China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neutropenia Biologic Drug Treatment Production Volume by Type (2018-2023)
-
Table Northwest China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neutropenia Biologic Drug Treatment Production Volume Share by Type (2018-2023)
-
Table Northwest China Neutropenia Biologic Drug Treatment Sales Volume by Application (2018-2023)
-
Table Northwest China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neutropenia Biologic Drug Treatment Sales Volume Share by Application (2018-2023)
-
Table Kyowa Kirin Company Profile
-
Table Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table Cellerant Therapeutics Company Profile
-
Table Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table CVS Health Company Profile
-
Table CVS Health Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table Baxter International Company Profile
-
Table Baxter International Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table Partner Therapeutics Company Profile
-
Table Partner Therapeutics Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Industries Ltd Company Profile
-
Table Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
Table Dong-A ST CO Ltd Company Profile
-
Table Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Revenue, Price and Gross (2018-2023)
-
